← Leaderboards
Desmond Slade
Midwest Research Institute
$4,490,363
Attributed
$4,490,363
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,490,363 · 3
By mechanism
N01$4,490,363 · 3
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Small Molecule”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Susan Abushakra · Alzheon, Inc.$50,765,244
- John Damon Chodera · Sloan-Kettering Inst Can Research$32,426,535
- Xinhua Li · Nano Terra, Inc.$29,432,783
- Leonard Freedman · Leidos Biomedical Research, Inc.$14,890,784
- Alan Johnson · Hawaii Biotech, Inc.$14,045,226
Research focus
Small MoleculeAlzheimer&AposS DiseaseTuberculosis TreatmentAntibiotic TherapyValidationAdverse EffectsAuditoryCessation Of LifeChemistryContractorDizzinessEquilibriumHair CellsSide EffectImpairmentInfectionAerobicAffectLabyrinthManufactureMethod DevelopmentMycobacterialNatural Killer Cells
Grant awards (9)
PROCESS DEVELOPMENT OF TELACEBEC FOR TUBERCULOSIS$136,605
N01 · FY2025 · DA · contact PI
PROCESS DEVELOPMENT OF TELACEBEC FOR TUBERCULOSIS$605,287
N01 · FY2024 · DA · contact PI
ANALYTICAL METHOD DEVELOPMENT, VALIDATION AND STABILITY STUDY OF ORC-13661$20,648
N01 · FY2024 · DA · contact PI
MRI GLOBAL - MILLER DMFP$1,311,541
N01 · FY2023 · DA · contact PI
MRIGLOBAL - WAGNER DMFP$313,538
N01 · FY2023 · DA · contact PI
ANALYTICAL METHOD DEVELOPMENT, VALIDATION AND STABILITY STUDY OF ORC-13661$288,603
N01 · FY2023 · DA · contact PI
MRIGLOBAL - WAGNER DMFP$263,060
N01 · FY2022 · DA · contact PI
MRIGLOBAL - WAGNER DMFP$958,940
N01 · FY2020 · DA · contact PI
MRI GLOBAL - MILLER DMFP$592,141
N01 · FY2020 · DA · contact PI